| Solid Lipid Nanoparticle Formulations of Docetaxel Prepared with High Melting Point Triglycerides: In Vitro and in Vivo Evaluation YW Naguib, BL Rodriguez, X Li, SD Hursting, RO Williams III, Z Cui Molecular pharmaceutics 11 (4), 1239-1249, 2014 | 129 | 2014 |
| Biodistribution and in Vivo Activities of Tumor-Associated Macrophage-Targeting Nanoparticles Incorporated with Doxorubicin M Niu, YW Naguib, AM Aldayel, Y Shi, SD Hursting, MA Hersh, Z Cui Molecular Pharmaceutics 11 (12), 4425-4436, 2014 | 98 | 2014 |
| Nanoparticle-based delivery of CRISPR/Cas9 genome-editing therapeutics BE Givens, YW Naguib, SM Geary, EJ Devor, AK Salem The AAPS journal 20, 1-22, 2018 | 88 | 2018 |
| Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer V Saxena, Y Naguib, MD Hussain Colloids and Surfaces B: Biointerfaces 94, 274-280, 2012 | 87 | 2012 |
| The effect of microneedles on the skin permeability and antitumor activity of topical 5-fluorouracil YW Naguib, A Kumar, Z Cui Acta Pharmaceutica Sinica B 4 (1), 94-99, 2014 | 82 | 2014 |
| Tumor-associated macrophage-mediated targeted therapy of triple-negative breast cancer M Niu, S Valdes, YW Naguib, SD Hursting, Z Cui Molecular pharmaceutics 13 (6), 1833-1842, 2016 | 71 | 2016 |
| Applications of bacillus Calmette–Guerin and recombinant bacillus Calmette–Guerin in vaccine development and tumor immunotherapy Y Zheng, YW Naguib, Y Dong, Y Shi, S Bou, Z Cui Expert review of vaccines 14 (9), 1255-1275, 2015 | 65 | 2015 |
| Acid-sensitive sheddable PEGylated PLGA nanoparticles increase the delivery of TNF-α siRNA in chronic inflammation sites AM Aldayel, YW Naguib, HL O'mary, X Li, M Niu, TB Ruwona, Z Cui Molecular Therapy-Nucleic Acids 5, 2016 | 49 | 2016 |
| Prednisolone-Loaded PLGA Microspheres. In Vitro Characterization and In Vivo Application in Adjuvant-Induced Arthritis in Mice KA Khaled, HA Sarhan, MA Ibrahim, AH Ali, YW Naguib Aaps Pharmscitech 11, 859-869, 2010 | 47 | 2010 |
| A method to improve the efficacy of topical eflornithine hydrochloride cream A Kumar, YW Naguib, Y Shi, Z Cui Drug delivery 23 (5), 1495-1501, 2016 | 43 | 2016 |
| Modified spraying technique and response surface methodology for the preparation and optimization of propolis liposomes of enhanced anti-proliferative activity against human … H Refaat, YW Naguib, MMA Elsayed, HAA Sarhan, E Alaaeldin Pharmaceutics 11 (11), 558, 2019 | 39 | 2019 |
| Nanomedicine: The promise and challenges in cancer chemotherapy YW Naguib, Z Cui Nanomaterial: Impacts on Cell Biology and Medicine, 207-233, 2014 | 32 | 2014 |
| In vivo distribution of zoledronic acid in a bisphosphonate-metal complex-based nanoparticle formulation synthesized by a reverse microemulsion method X Li, YW Naguib, Z Cui International journal of pharmaceutics 526 (1-2), 69-76, 2017 | 29 | 2017 |
| Gastro-retentive oral drug delivery systems: A promising approach for narrow absorption window drugs M Ibrahim, YW Naguib, HA Sarhan, H Abdelkader Journal of advanced Biomedical and Pharmaceutical Sciences 2 (3), 98-110, 2019 | 28 | 2019 |
| Reverse Microemulsion-Based Synthesis of (Bis) phosphonate–Metal Materials with Controllable Physical Properties: An Example Using Zoledronic Acid–Calcium Complexes X Li, YW Naguib, S Valdes, S Hufnagel, Z Cui ACS applied materials & interfaces 9 (16), 14478-14489, 2017 | 20 | 2017 |
| Acid-sensitive sheddable PEGylated, mannose-modified nanoparticles increase the delivery of betamethasone to chronic inflammation sites in a mouse model HL O’Mary, AM Aldayel, SA Valdes, YW Naguib, X Li, K Salvady, Z Cui Molecular pharmaceutics 14 (6), 1929-1937, 2017 | 16 | 2017 |
| Solubilized ubiquinol for preserving corneal function YW Naguib, S Saha, JM Skeie, T Acri, K Ebeid, S Abdel-Rahman, S Kesh, ... Biomaterials 275, 120842, 2021 | 15 | 2021 |
| Synthesis, characterization, and in vitro and in vivo evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with potent and broad-spectrum antitumor activity YW Naguib, D Lansakara-P, LM Lashinger, BL Rodriguez, S Valdes, ... Neoplasia 18 (1), 33-48, 2016 | 15 | 2016 |
| An injectable microparticle formulation for the sustained release of the specific MEK inhibitor PD98059: in vitro evaluation and pharmacokinetics YW Naguib, BE Givens, G Ho, Y Yu, SG Wei, RM Weiss, RB Felder, ... Drug delivery and translational research 11, 182-191, 2021 | 13 | 2021 |
| Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAFV600E melanoma-bearing mice AI Mekkawy, YW Naguib, SO Alhaj-Suliman, EI Wafa, K Ebeid, T Acri, ... International journal of pharmaceutics 606, 120876, 2021 | 12 | 2021 |
Stephen HurstingProfessor of Nutrition, University of North CarolinaVerified email at email.unc.edu
